Dendreon vs CMS: why the Provenge coverage controversy is bigger than just one product.
Prevision Policy, LLC.
Ramsey
R
Baghdadi
D019496:Cancer Vaccines / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D008297:Male; D006278:Medicare; D011471:Prostatic Neoplasms / Q000628:therapy*; D014020:Tissue Extracts / Q000627:therapeutic use*; D014481:United States
D019496:Cancer Vaccines; D014020:Tissue Extracts; C511774:sipuleucel-T